Nuvectis Pharma
NVCT
NVCT
47 hedge funds and large institutions have $24.2M invested in Nuvectis Pharma in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
15% more call options, than puts
Call options by funds: $569K | Put options by funds: $495K
6.77% more ownership
Funds ownership: 8.75% → 15.52% (+6.8%)
Holders
47
Holding in Top 10
–
Calls
$569K
Puts
$495K
Top Buyers
| 1 | +$5.21M | |
| 2 | +$1.81M | |
| 3 | +$1.36M | |
| 4 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$1.08M |
| 5 |
State Street
Boston,
Massachusetts
|
+$778K |
Top Sellers
| 1 | -$918K | |
| 2 | -$816K | |
| 3 | -$446K | |
| 4 |
Jane Street
New York
|
-$413K |
| 5 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$321K |